The results improve our understanding of how substrate specificity is determined in amino acid transporters and provide a framework for developing potent chemical tools and potential drugs targeting ASCT2, an emerging therapeutic target for cancer and neurological disorders. The gene discussed is SLC1A5; the disease is cancer.